10x Genomics
Stock Forecast, Prediction & Price Target
10x Genomics Financial Estimates
10x Genomics Revenue Estimates
10x Genomics EBITDA Estimates
10x Genomics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $490.49M N/A | $516.40M 5.28% | $618.72M 19.81% | Avg: $765.34M Low: $737.76M High: $790.27M avg. 23.69% | Avg: $873.35M Low: $841.85M High: $894.62M avg. 14.11% | Avg: $973.45M Low: $938.33M High: $997.15M avg. 11.46% | Avg: $1.11B Low: $1.07B High: $1.14B avg. 14.83% |
Net Income
% change YoY
| $-58.22M N/A | $-166M -185.11% | $-255.09M -53.67% | Avg: $-117.70M Low: $-178.09M High: $-50.59M avg. 53.85% | Avg: $-41.40M Low: $-136.03M High: $52.72M avg. 64.82% | Avg: $4.10M Low: $3.90M High: $4.23M avg. 109.90% | Avg: $26.94M Low: $25.68M High: $27.80M avg. 557.14% |
EBITDA
% change YoY
| $-53.50M N/A | $-161.49M -201.80% | $-205.11M -27.00% | Avg: $-162.41M Low: $-167.70M High: $-156.56M avg. 20.81% | Avg: $-185.33M Low: $-189.85M High: $-178.65M avg. -14.11% | Avg: $-206.58M Low: $-211.61M High: $-199.12M avg. -11.46% | Avg: $-237.22M Low: $-242.99M High: $-228.66M avg. -14.83% |
EPS
% change YoY
| -$0.53 N/A | -$1.46 -175.47% | -$2.18 -49.31% | Avg: -$1 Low: -$1.52 High: -$0.43 avg. 53.94% | Avg: -$0.35 Low: -$1.16 High: $0.45 avg. 65.03% | Avg: $0.04 Low: $0.03 High: $0.04 avg. 109.97% | Avg: $0.23 Low: $0.22 High: $0.24 avg. 557.14% |
Operating Expenses
% change YoY
| $469.31M N/A | $563.96M 20.16% | $674.94M 19.67% | Avg: $438.19M Low: $422.40M High: $452.47M avg. -35.07% | Avg: $500.03M Low: $482.00M High: $512.21M avg. 14.11% | Avg: $557.34M Low: $537.24M High: $570.92M avg. 11.46% | Avg: $640.01M Low: $616.92M High: $655.60M avg. 14.83% |
FAQ
What is 10x Genomics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 196.43% in 2025-2028.
We have gathered data from 13 analysts. Their low estimate is -178.09M, average is -117.70M and high is -50.59M.
What is 10x Genomics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 16.02% in 2025-2028.
We have gathered data from 12 analysts. Their low revenue estimate is $737.76M, average is $765.34M and high is $790.27M.
What is 10x Genomics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 196.52% in 2025-2028.
We have gathered data from 13 analysts. Their low earnings per share estimate is -$1.52, average is -$1 and high is $-0.43.
What is the best performing analyst?
In the last twelve months analysts have been covering 10x Genomics stock. The most successful analyst is Justin Bowers.